News + Filings Holdings
All
13F
13D/G
Other
|
|
New Leaf Biopharma Opportunities II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/15/2019 |
4
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 250,009 shares
@ $35, valued at
$8.8M
Sold 49,991 shares
@ $35, valued at
$1.7M
|
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/06/2018 |
SC 13G
| New Leaf Biopharma Opportunities II, L.P. reports a 8.6% stake in Proteon Therapeutics, Inc. |
| 09/20/2018 |
4
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Converted 1,070,771 shares
@ $0
Converted 312,741 shares
@ $0
Converted 260,617 shares
@ $0
Converted 544,047 shares
@ $0
Converted 167,537 shares
@ $0
Bought 270,000 shares
@ $17, valued at
$4.6M
Converted 1,070,771 convertible preferred
@ $0
Converted 312,741 convertible preferred
@ $0
Converted 260,617 convertible preferred
@ $0
Converted 544,047 convertible preferred
@ $0
Converted 167,537 convertible preferred
@ $0 |
|
| 09/13/2018 |
3
| New Leaf Ventures II, L.P. (10% Owner) has filed a Form 3 on Principia Biopharma Inc. |
| 07/24/2018 |
SC 13G
| New Leaf Biopharma Opportunities II, L.P. reports a 6.2% stake in Versartis, Inc. |
| 04/16/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
|
|